A New Approach to Establish a Cell Line with Reduced Risk of Endogenous Retroviruses

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Fukuma, Aiko ^a   Yoshikawa, Rokusuke ^b   Miyazawa, Takayuki ^b   Yasuda, Jiro ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LIVE VACCINE; MEMBRANE PROTEIN; TETHERIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CELL LINE; CELL VIABILITY; CRANDELL REES FELINE KIDNEY CELL; ENDOGENOUS RETROVIRUS; HUMAN; HUMAN CELL; NONHUMAN; PARVOVIRUS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RISK REDUCTION; VACCINE PRODUCTION; VIRAL CONTAMINATION; VIROGENESIS; VIRUS RELEASE; VIRUS REPLICATION;

ANIMALS; ANTIGENS, CD; CATS; CELL ENGINEERING; CELL LINE; DRUG CONTAMINATION; ENDOGENOUS RETROVIRUSES; FOUNDER EFFECT; GENE EXPRESSION; GPI-LINKED PROTEINS; HUMANS; KIDNEY; PARVOVIRUS; RISK; TRANSFECTION; UROTHELIUM; VACCINES; VACCINES, ATTENUATED; VIRUS RELEASE; VIRUS REPLICATION;

FELIDAE; MAMMALIA; PARVOVIRUS;

EID: 84876063070     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061530     Document Type: Article

References (34)

1. Gifford R, Tristem M, (2003) The evolution, distribution and diversity of endogenous retroviruses. Virus genes 26: 291-315.
2. Baumann JG, Gunzburg WH, Salmons B, (1998) CrFK feline kidney cells produce an RD114-like endogenous virus that can package murine leukemia virus-based vectors. J Virol 72: 7685-7687.
3. Ma H, Ma Y, Ma W, Williams DK, Galvin TA, et al. (2011) Chemical induction of endogenous retrovirus particles from the vero cell line of African green monkeys. Journal of virology 85: 6579-6588.
4. Miyazawa T, (2010) Endogenous retroviruses as potential hazards for vaccines. Biologicals: journal of the International Association of Biological Standardization 38: 371-376.
5. Miyazawa T, Yoshikawa R, Golder M, Okada M, Stewart H, et al. (2010) Isolation of an infectious endogenous retrovirus in a proportion of live attenuated vaccines for pets. J Virol 84: 3690-3694.
6. Yoshikawa R, Sato E, Miyazawa T, (2011) Contamination of infectious RD-114 virus in vaccines produced using non-feline cell lines. Biologicals 39: 33-37.
7. Yoshikawa R, Sato E, Miyazawa T, (2012) Presence of Infectious RD-114 Virus in a Proportion of Canine Parvovirus Isolates. The Journal of veterinary medical science/the Japanese Society of Veterinary Science 74: 347-350.
8. Okabe H, Gilden RV, Hatanaka M, (1973) RD 114 virus-specific sequences in feline cellular RNA: detection and characterization. J Virol 12: 984-994.
9. Fischinger PJ, Peebles PT, Nomura S, Haapala DK, (1973) Isolation of RD-114-like oncornavirus from a cat cell line. J Virol 11: 978-985.
10. Yoshikawa R, Sato E, Igarashi T, Miyazawa T, (2010) Characterization of RD-114 virus isolated from a commercial canine vaccine manufactured using CRFK cells. J Clin Microbiol 48: 3366-3369.
11. Okada M, Yoshikawa R, Shojima T, Baba K, Miyazawa T, (2011) Susceptibility and production of a feline endogenous retrovirus (RD-114 virus) in various feline cell lines. Virus Res 155: 268-273.
12. Neil SJ, Zang T, Bieniasz PD, (2008) Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 451: 425-430.
13. Van Damme N, Goff D, Katsura C, Jorgenson RL, Mitchell R, et al. (2008) The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein. Cell host & microbe 3: 245-252.
14. Sakuma T, Noda T, Urata S, Kawaoka Y, Yasuda J, (2009) Inhibition of Lassa and Marburg virus production by tetherin. J Virol 83: 2382-2385.
15. Jouvenet N, Neil SJ, Zhadina M, Zang T, Kratovac Z, et al. (2009) Broad-spectrum inhibition of retroviral and filoviral particle release by tetherin. Journal of virology 83: 1837-1844.
16. Kaletsky RL, Francica JR, Agrawal-Gamse C, Bates P, (2009) Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein. Proceedings of the National Academy of Sciences of the United States of America 106: 2886-2891.
17. Mansouri M, Viswanathan K, Douglas JL, Hines J, Gustin J, et al. (2009) Molecular mechanism of BST2/tetherin downregulation by K5/MIR2 of Kaposi's sarcoma-associated herpesvirus. Journal of virology 83: 9672-9681.
18. Mattiuzzo G, Ivol S, Takeuchi Y, (2010) Regulation of porcine endogenous retrovirus release by porcine and human tetherins. Journal of virology 84: 2618-2622.
19. Gottlinger HG, Dorfman T, Cohen EA, Haseltine WA, (1993) Vpu protein of human immunodeficiency virus type 1 enhances the release of capsids produced by gag gene constructs of widely divergent retroviruses. Proceedings of the National Academy of Sciences of the United States of America 90: 7381-7385.
20. Goffinet C, Schmidt S, Kern C, Oberbremer L, Keppler OT, (2010) Endogenous CD317/Tetherin limits replication of HIV-1 and murine leukemia virus in rodent cells and is resistant to antagonists from primate viruses. J Virol 84: 11374-11384.
21. Liberatore RA, Bieniasz PD, (2011) Tetherin is a key effector of the antiretroviral activity of type I interferon in vitro and in vivo. Proc Natl Acad Sci U S A 108: 18097-18101.
22. Barrett BS, Smith DS, Li SX, Guo K, Hasenkrug KJ, et al. (2012) A single nucleotide polymorphism in tetherin promotes retrovirus restriction in vivo. PLoS Pathog 8: e1002596.
23. Groom HC, Yap MW, Galao RP, Neil SJ, Bishop KN, (2010) Susceptibility of xenotropic murine leukemia virus-related virus (XMRV) to retroviral restriction factors. Proc Natl Acad Sci U S A 107: 5166-5171.
24. Fukuma A, Abe M, Morikawa Y, Miyazawa T, Yasuda J, (2011) Cloning and characterization of the antiviral activity of feline Tetherin/BST-2. PloS one 6: e18247.
25. Kupzig S, Korolchuk V, Rollason R, Sugden A, Wilde A, et al. (2003) Bst-2/HM1.24 is a raft-associated apical membrane protein with an unusual topology. Traffic 4: 694-709.
26. Perez-Caballero D, Zang T, Ebrahimi A, McNatt MW, Gregory DA, et al. (2009) Tetherin inhibits HIV-1 release by directly tethering virions to cells. Cell 139: 499-511.
27. Fukuma A, Abe M, Urata S, Yoshikawa R, Morikawa Y, et al. (2011) Viral and cellular requirements for the budding of Feline Endogenous Retrovirus RD-114. Virology journal 8: 540.
28. Sakaguchi S, Okada M, Shojima T, Baba K, Miyazawa T, (2008) Establishment of a LacZ marker rescue assay to detect infectious RD114 virus. The Journal of veterinary medical science/the Japanese Society of Veterinary Science 70: 785-790.
29. Nakata R, Miyazawa T, Shin YS, Watanabe R, Mikami T, et al. (2003) Reevaluation of host ranges of feline leukemia virus subgroups. Microbes and infection/Institut Pasteur 5: 947-950.
30. Konishi S, Mochizuki M, Ogata M, (1975) Studies on feline panleukopenia. I. Isolation and properties of virus strains. Nihon juigaku zasshi The Japanese journal of veterinary science 37: 247-257.
31. Miyazawa T, Ikeda Y, Nakamura K, Naito R, Mochizuki M, et al. (1999) Isolation of feline parvovirus from peripheral blood mononuclear cells of cats in northern Vietnam. Microbiology and immunology 43: 609-612.
32. Ikeda Y, Miyazawa T, Kurosawa K, Naito R, Hatama S, et al. (1998) New quantitative methods for detection of feline parvovirus (FPV) and virus neutralizing antibody against FPV using a feline T lymphoid cell line. The Journal of veterinary medical science/the Japanese Society of Veterinary Science 60: 973-974.
33. Sassa Y, Fukui D, Takeshi K, Miyazawa T, (2006) Neutralizing antibodies against feline parvoviruses in nondomestic felids inoculated with commercial inactivated polyvalent vaccines. The Journal of veterinary medical science/the Japanese Society of Veterinary Science 68: 1195-1198.
34. Narushima R, Shimazaki T, Takahashi T, (2011) Development of a real-time reverse-transcription-PCR method for detection of RD114 virus in canine vaccines. Biologicals: journal of the International Association of Biological Standardization 39: 89-93.